Pteridines useful as HCV inhibitors and methods for the preparation thereof

Details for Australian Patent Application No. 2006245675 (hide)

Owner Tibotec Pharmaceuticals Ltd.

Inventors Surleraux, Dominique Louis Nestor Ghislain; Lenz, Oliver; Raboisson, Pierre Jean-Marie Bernard; Lin, Tse-I; Simmen, Kenneth Alan

Agent Shelston IP

Pub. Number AU-B-2006245675

PCT Pub. Number WO2006/120251

Priority 06075854.7 06.04.06 EP; 05106212.3 07.07.05 EP; 60/680,393 12.05.05 US

Filing date 12 May 2006

Wipo publication date 16 November 2006

Acceptance publication date 14 April 2011

International Classifications

C07D 475/10 (2006.01) Heterocyclic compounds containing pteridine ring systems

A61K 31/519 (2006.01) - ortho- or peri-condensed with heterocyclic rings

A61P 31/14 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Event Publications

15 November 2007 PCT application entered the National Phase

  PCT publication WO2006/120251 Priority application(s): WO2006/120251

14 April 2011 Application Accepted

  Published as AU-B-2006245675

11 August 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006245676-Pyrido(2,3-d)pyrimidines useful as HCV inhibitors, and methods for the preparation thereof

2006245664-Low-temperature fused-salt electrolysis of quartz